Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Biomerica - 45 Year Stock Price History | BMRA

Historical daily share price chart and data for Biomerica since 1980 adjusted for splits and dividends. The latest closing stock price for Biomerica as of November 07, 2025 is 2.46.
  • The all-time high Biomerica stock closing price was 292.00 on November 12, 1980.
  • The Biomerica 52-week high stock price is 10.16, which is 313% above the current share price.
  • The Biomerica 52-week low stock price is 2.08, which is 15.4% below the current share price.
  • The average Biomerica stock price for the last 52 weeks is 3.57.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Biomerica Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.7346 2.4240 8.2400 2.4240 2.4600 2.47%
2024 4.6355 10.0800 10.3200 2.1280 2.4008 -75.99%
2023 12.6868 27.4400 28.4800 5.6800 10.0000 -62.69%
2022 29.0894 33.2800 37.5200 20.8800 26.8000 -13.88%
2021 39.0105 40.4800 64.0000 27.2800 31.1200 -21.89%
2020 50.4616 23.2800 128.0000 18.9600 39.8400 64.68%
2019 21.7976 15.5200 28.2400 15.3296 24.1920 77.88%
2018 29.2681 31.7600 42.4000 13.6000 13.6000 -54.55%
2017 21.7770 17.2800 35.4400 15.7600 29.9200 62.61%
2016 15.6782 10.4000 25.9200 8.6400 18.4000 78.29%
2015 7.2328 6.5600 10.3200 5.7600 10.3200 44.94%
2014 6.9060 6.2400 8.2400 5.6088 7.1200 14.10%
2013 7.5886 6.4400 10.0000 5.6000 6.2400 -7.36%
2012 5.8247 3.4400 7.1200 3.4400 6.7360 75.42%
2011 3.5328 3.3200 3.9200 2.8000 3.8400 15.66%
2010 3.4048 3.0080 4.2400 2.9600 3.3200 1.22%
2009 3.7758 3.6000 5.6000 2.8000 3.2800 -21.15%
2008 7.5966 11.6000 11.8400 3.6000 4.1600 -66.45%
2007 8.4995 3.2000 14.4000 3.0400 12.4000 287.50%
2006 3.8246 3.6800 4.7200 3.2000 3.2000 -16.67%
2005 3.8353 3.2000 6.0000 3.0400 3.8400 17.07%
2004 3.6870 4.0000 5.2000 2.5600 3.2800 -8.89%
2003 2.9599 1.8400 4.4000 1.5200 3.6000 114.29%
2002 3.5989 5.3600 5.6000 1.4400 1.6800 -68.18%
2001 6.2782 6.5000 9.7500 3.3600 5.2800 62.46%
2000 14.9590 24.5000 32.5000 3.0000 3.2500 -86.17%
1999 18.6494 9.0000 32.5000 7.5000 23.5000 193.75%
1998 13.7930 24.0000 24.5000 6.5000 8.0000 -65.96%
1997 22.4782 28.0000 33.0000 17.0000 23.5000 -9.62%
1996 27.6564 19.0000 78.0000 15.0000 26.0000 36.84%
1995 13.0415 10.0000 20.0000 7.0000 19.0000 171.43%
1994 13.5215 17.0000 18.5000 7.0000 7.0000 -58.82%
1993 18.7678 22.0000 27.0000 16.0000 17.0000 -22.73%
1992 29.8399 32.0000 50.0000 16.0000 22.0000 -31.25%
1991 16.4023 4.2500 54.0160 3.0000 32.0000 652.94%
1990 4.8397 5.7600 7.2640 3.7600 4.2500 -26.22%
1989 10.5871 11.0000 15.0000 5.5000 5.7600 -47.64%
1988 14.1839 15.0000 22.5000 10.0000 11.0000 -21.43%
1987 47.6245 56.0000 72.0000 14.0000 14.0000 -75.00%
1986 69.4466 66.0000 96.0000 44.0000 56.0000 -9.68%
1985 77.0040 44.0000 104.0000 44.0000 62.0000 34.78%
1984 49.1858 56.0000 68.0000 36.0000 46.0000 -14.81%
1983 90.2302 80.0000 140.0000 48.0000 54.0000 -32.50%
1982 45.3597 46.0000 82.0000 26.0000 80.0000 66.67%
1981 96.1587 136.0000 154.0000 42.0000 48.0000 -63.64%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.005B
BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include medical universities, pharmaceutical companies, hospitals, clinics, commercial laboratories, physician's offices and consumers.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.709B 30.27
Zoetis (ZTS) United States $52.989B 18.97
Takeda Pharmaceutical (TAK) Japan $43.466B 8.87
Daiichi Sankyo, - (DSNKY) Japan $41.562B 20.70
BeOne Medicines - (ONC) Switzerland $35.089B 186.03
Sandoz Group AG (SDZNY) Switzerland $29.014B 0.00
United Therapeutics (UTHR) United States $19.329B 17.01
Merck (MKKGY) Germany $16.401B 10.66
Neurocrine Biosciences (NBIX) United States $15.192B 36.45
Shionogi (SGIOY) Japan $14.411B 13.23
Summit Therapeutics (SMMT) United States $14.020B 0.00
Ionis Pharmaceuticals (IONS) United States $11.913B 0.00
IPSEN (IPSEY) France $11.841B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.112B 0.00
Orion OYJ (ORINY) Finland $8.719B 24.91
Eisai (ESAIY) $8.166B 0.00
Corcept Therapeutics (CORT) United States $7.754B 83.77
Stevanato Group S.p.A (STVN) Italy $7.299B 40.85
Grifols, S.A (GRFS) Spain $5.803B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.546B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.140B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.767B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.571B 16.97
Centessa Pharmaceuticals (CNTA) United Kingdom $2.962B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 22.24
Catalyst Pharmaceuticals (CPRX) United States $2.629B 8.39
Dyne Therapeutics (DYN) United States $2.622B 0.00
Soleno Therapeutics (SLNO) United States $2.562B 0.00
Ocular Therapeutix (OCUL) United States $2.312B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.926B 22.83
Guardian Pharmacy Services (GRDN) United States $1.824B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.815B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.493B 88.63
Ardelyx (ARDX) United States $1.358B 0.00
Collegium Pharmaceutical (COLL) United States $1.333B 6.62
Harrow (HROW) United States $1.255B 0.00
Xeris Biopharma Holdings (XERS) United States $1.200B 0.00
Oruka Therapeutics (ORKA) United States $1.153B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.098B 0.00
Evotec AG (EVO) Germany $1.094B 0.00
Nektar Therapeutics (NKTR) United States $1.064B 0.00
Enliven Therapeutics (ELVN) United States $1.044B 0.00
Relay Therapeutics (RLAY) United States $1.043B 0.00
Xencor (XNCR) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
ARS Pharmaceuticals (SPRY) United States $0.875B 0.00
ProKidney (PROK) United States $0.850B 0.00
Theravance Biopharma (TBPH) United States $0.743B 61.46
Aquestive Therapeutics (AQST) United States $0.737B 0.00
Organogenesis (ORGO) United States $0.714B 0.00
Savara (SVRA) United States $0.683B 0.00
Elite Pharmaceuticals (ELTP) United States $0.674B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.639B 5.70
Bioventus (BVS) United States $0.616B 12.63
KalVista Pharmaceuticals (KALV) United States $0.545B 0.00
Akebia Therapeutics (AKBA) United States $0.541B 0.00
Esperion Therapeutics (ESPR) United States $0.536B 0.00
Zevra Therapeutics (ZVRA) United States $0.496B 0.00
4D Molecular Therapeutics (FDMT) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.468B 6.41
Lexeo Therapeutics (LXEO) United States $0.442B 0.00
Altimmune (ALT) United States $0.363B 0.00
USANA Health Sciences (USNA) United States $0.350B 9.76
Lyell Immunopharma (LYEL) United States $0.336B 0.00
Galectin Therapeutics (GALT) United States $0.335B 0.00
Korro Bio (KRRO) United States $0.318B 0.00
Nature's Sunshine Products (NATR) United States $0.316B 18.67
Ironwood Pharmaceuticals (IRWD) United States $0.312B 48.00
Larimar Therapeutics (LRMR) United States $0.286B 0.00
Aldeyra Therapeutics (ALDX) United States $0.282B 0.00
Aclaris Therapeutics (ACRS) United States $0.251B 0.00
Pyxis Oncology (PYXS) United States $0.243B 0.00
Journey Medical (DERM) United States $0.240B 0.00
Achieve Life Sciences (ACHV) Canada $0.235B 0.00
AleAnna (ANNA) United States $0.212B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
OmniAb (OABI) United States $0.199B 0.00
Avalo Therapeutics (AVTX) United States $0.198B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Protara Therapeutics (TARA) United States $0.166B 0.00
China SXT Pharmaceuticals (SXTC) China $0.159B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.149B 0.00
Cassava Sciences (SAVA) United States $0.143B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.112B 0.00
Surrozen (SRZN) United States $0.105B 0.00
Context Therapeutics (CNTX) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Avita Medical (RCEL) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.093B 33.70
Relmada Therapeutics (RLMD) United States $0.088B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Lite Strategy (LITS) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.073B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Prelude Therapeutics (PRLD) United States $0.067B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
Acrivon Therapeutics (ACRV) United States $0.059B 0.00
PolyPid (PYPD) Israel $0.058B 0.00
Talphera (TLPH) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.057B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
Plus Therapeutics (PSTV) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
Karyopharm Therapeutics (KPTI) United States $0.045B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Inotiv (NOTV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.63
Liminatus Pharma (LIMN) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Mangoceuticals (MGRX) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Vyome Holdings (HIND) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Heatwurx (PCSA) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Lipocine (LPCN) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
NewcelX (NCEL) Switzerland $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00